000274079 001__ 274079
000274079 005__ 20240229162318.0
000274079 0247_ $$2doi$$a10.1038/s41596-023-00805-y
000274079 0247_ $$2pmid$$apmid:36859615
000274079 0247_ $$2ISSN$$a1754-2189
000274079 0247_ $$2ISSN$$a1750-2799
000274079 0247_ $$2altmetric$$aaltmetric:143024111
000274079 037__ $$aDKFZ-2023-00425
000274079 041__ $$aEnglish
000274079 082__ $$a610
000274079 1001_ $$00000-0002-8915-4588$$aSpitzer, Daniel$$b0
000274079 245__ $$aA flow cytometry-based protocol for syngenic isolation of neurovascular unit cells from mouse and human tissues.
000274079 260__ $$aBasingstoke$$bNature Publishing Group$$c2023
000274079 3367_ $$2DRIVER$$aarticle
000274079 3367_ $$2DataCite$$aOutput Types/Journal article
000274079 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1685014857_26041$$xReview Article
000274079 3367_ $$2BibTeX$$aARTICLE
000274079 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000274079 3367_ $$00$$2EndNote$$aJournal Article
000274079 500__ $$a2023 May;18(5):1510-1542
000274079 520__ $$aThe neurovascular unit (NVU), composed of endothelial cells, pericytes, juxtaposed astrocytes and microglia together with neurons, is essential for proper central nervous system functioning. The NVU critically regulates blood-brain barrier (BBB) function, which is impaired in several neurological diseases and is therefore a key therapeutic target. To understand the extent and cellular source of BBB dysfunction, simultaneous isolation and analysis of NVU cells is needed. Here, we describe a protocol for the EPAM-ia method, which is based on flow cytometry for simultaneous isolation and analysis of endothelial cells, pericytes, astrocytes and microglia. This method is based on differential processing of NVU cell types using enzymes, mechanical homogenization and filtration specific for each cell type followed by combining them for immunostaining and fluorescence-activated cell sorting. The gating strategy encompasses cell-type-specific and exclusion markers for contaminating cells to isolate the major NVU cell types. This protocol takes ~6 h for two sets of one or two animals. The isolation part requires experience in animal handling, fresh tissue processing and immunolabeling for flow cytometry. Sorted NVU cells can be used for downstream applications including transcriptomics, proteomics and cell culture. Multiple cell-type analyses using UpSet can then be applied to obtain robust targets from single or multiple NVU cell types in neurological diseases associated with BBB dysfunction. The EPAM-ia method is also amenable to isolation of several other cell types, including cancer cells and immune cells. This protocol is applicable to healthy and pathological tissue from mouse and human sources and to several cell types compared with similar protocols.
000274079 536__ $$0G:(DE-HGF)POF4-899$$a899 - ohne Topic (POF4-899)$$cPOF4-899$$fPOF IV$$x0
000274079 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
000274079 7001_ $$aKhel, Maryam I$$b1
000274079 7001_ $$aPütz, Tim$$b2
000274079 7001_ $$aZinke, Jenny$$b3
000274079 7001_ $$aJia, Xiaoxiong$$b4
000274079 7001_ $$aSommer, Kathleen$$b5
000274079 7001_ $$aFilipski, Katharina$$b6
000274079 7001_ $$aThorsen, Frits$$b7
000274079 7001_ $$aFreiman, Thomas M$$b8
000274079 7001_ $$aGünther, Stefan$$b9
000274079 7001_ $$0P:(DE-HGF)0$$aPlate, Karl H$$b10
000274079 7001_ $$0P:(DE-He78)b15b56a6ed37417d476470c60c0140ff$$aHarter, Patrick$$b11
000274079 7001_ $$00000-0002-4656-2258$$aLiebner, Stefan$$b12
000274079 7001_ $$0P:(DE-HGF)0$$aReiss, Yvonne$$b13
000274079 7001_ $$aDi Tacchio, Mariangela$$b14
000274079 7001_ $$aGuérit, Sylvaine$$b15
000274079 7001_ $$00000-0002-5005-3413$$aDevraj, Kavi$$b16
000274079 773__ $$0PERI:(DE-600)2244966-8$$a10.1038/s41596-023-00805-y$$n5$$p1510-1542$$tNature protocols$$v18$$x1754-2189$$y2023
000274079 909CO $$ooai:inrepo02.dkfz.de:274079$$pVDB
000274079 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b10$$kDKFZ
000274079 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)b15b56a6ed37417d476470c60c0140ff$$aDeutsches Krebsforschungszentrum$$b11$$kDKFZ
000274079 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b13$$kDKFZ
000274079 9131_ $$0G:(DE-HGF)POF4-899$$1G:(DE-HGF)POF4-890$$2G:(DE-HGF)POF4-800$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bProgrammungebundene Forschung$$lohne Programm$$vohne Topic$$x0
000274079 9141_ $$y2023
000274079 915__ $$0StatID:(DE-HGF)3003$$2StatID$$aDEAL Nature$$d2022-11-17$$wger
000274079 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2022-11-17
000274079 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2022-11-17
000274079 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz$$d2023-10-25$$wger
000274079 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2023-10-25
000274079 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2023-10-25
000274079 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2023-10-25
000274079 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2023-10-25
000274079 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2023-10-25
000274079 9201_ $$0I:(DE-He78)FM01-20160331$$kFM01$$lDKTK FM zentral$$x0
000274079 980__ $$ajournal
000274079 980__ $$aVDB
000274079 980__ $$aI:(DE-He78)FM01-20160331
000274079 980__ $$aUNRESTRICTED